UB Paderborn / Katalog / Suche / in CDI

1 – 23 von 23

Sortiert nach

Prescription Opioids. IV: Disposition of Hydrocodone in Oral Fluid and Blood Following Single-Dose Administration

Journal of analytical toxicology, 2015-09, Vol.39 (7), p.510-518

2015

Volltextzugriff (PDF)

Oxycodone/Naloxone: Role in Chronic Pain Management, Opioid-Induced Constipation, and Abuse Deterrence

Pain and therapy, 2014-06, Vol.3 (1), p.1-15

2014

Volltextzugriff (PDF)

Prescription Opioids. III. Disposition of Oxycodone in Oral Fluid and Blood Following Controlled Single-Dose Administration

Journal of analytical toxicology, 2015-04, Vol.39 (3), p.192-202

2015

Volltextzugriff (PDF)

Prevalence of Synthetic Cannabinoids in U.S. Athletes: Initial Findings

Journal of analytical toxicology, 2012-10, Vol.36 (8), p.588-593

2012

Volltextzugriff (PDF)

Immunoassay in healthcare testing applications

Journal of opioid management, 2015-01, Vol.11 (1), p.13

2015

Volltextzugriff (PDF)

Prescription Opioids. V. Metabolism and Excretion of Oxymorphone in Urine Following Controlled Single Dose Administration

Journal of analytical toxicology, 2016-10, Vol.40 (8), p.566-574

2016

Volltextzugriff (PDF)

Prescription Opioids. VI. Metabolism and Excretion of Hydromorphone in Urine Following Controlled Single-Dose Administration

Journal of analytical toxicology, 2016-10, Vol.40 (8), p.575-582

2016

Volltextzugriff (PDF)

Pseudoephedrine and False-Positive Immunoassay Urine Drug Tests for Amphetamine

Pharmacotherapy, 2013-05, Vol.33 (5), p.e88-e89

2013

Volltextzugriff (PDF)

Uncertainty in Assessing Impact of Drug–Drug Interactions on Oxycodone Metabolite Patterns

Journal of analytical toxicology, 2014-09, Vol.38 (7), p.462-462

2014

Volltextzugriff (PDF)

Risks and Responsibilities in Prescribing Opioids for Chronic Noncancer Pain, Part 2: Best Practices

Postgraduate medicine, 2014-11, Vol.126 (7), p.129-138

2014

Volltextzugriff (PDF)

Determining Zolpidem Compliance: Urinary Metabolite Detection and Prevalence in Chronic Pain Patients

Journal of analytical toxicology, 2014-10, Vol.38 (8), p.513-518

2014

Volltextzugriff (PDF)

Prescribing Opioids for Chronic Noncancer Pain in Primary Care: Risk Assessment

Postgraduate medicine, 2014-09, Vol.126 (5), p.159-166

2014

Volltextzugriff (PDF)

Oral Fluid Drug Testing of Chronic Pain Patients. II. Comparison of Paired Oral Fluid and Urine Specimens

Journal of analytical toxicology, 2012-03, Vol.36 (2), p.75-80

2012

Volltextzugriff (PDF)

Oral Fluid Drug Testing of Chronic Pain Patients. I. Positive Prevalence Rates of Licit and Illicit Drugs

Journal of analytical toxicology, 2011-10, Vol.35 (8), p.529-540

2011

Volltextzugriff (PDF)

Prevalence of heroin markers in urine for pain management patients

Forensic science international, 2014-10, Vol.243, p.79-83

2014

Volltextzugriff (PDF)

Urine Drug Testing of Chronic Pain Patients. V. Prevalence of Propoxyphene Following its Withdrawal from the United States Market

Journal of analytical toxicology, 2013-01, Vol.37 (1), p.1-4

2013

Volltextzugriff (PDF)

Urine Drug Testing of Chronic Pain Patients. III. Normetabolites as Biomarkers of Synthetic Opioid Use

Journal of analytical toxicology, 2010-10, Vol.34 (8), p.444-449

2010

Volltextzugriff (PDF)

Urine Drug Testing of Chronic Pain Patients. IV. Prevalence of Gabapentin and Pregabalin

Journal of analytical toxicology, 2011-07, Vol.35 (6), p.357-359

2011

Volltextzugriff (PDF)

Drug Testing in Pain Management

Principles of Forensic Toxicology, p.77-89

Volltextzugriff (PDF)

Intralesional lymphokine-activated killer cells as adjuvant therapy for primary glioblastoma

Journal of immunotherapy, 2009-11, Vol.32 (9), p.914-919

2009

Volltextzugriff (PDF)

Long-term survival for patients with detectable metastatic melanoma at time of treatment with patient-specific tumor stem cell vaccines

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.3090-3090

2014

Volltextzugriff (PDF)

Patient-specific immunotherapy utilizing putative tumor stem cells in patients with metastatic melanoma: A pooled analysis comparing tumor cell and dendritic cell vaccines in two phase II trials and a randomized phase II trial

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.2569-2569

2012

Volltextzugriff (PDF)

Evidence for a unifocal origin in familial ovarian cancer

American journal of obstetrics and gynecology, 1996-04, Vol.174 (4), p.1102-1108

1996

Volltextzugriff (PDF)

1 – 23 von 23

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(22)
Buchkapitel
(1)

Sprache

Englisch
(23)
Japanisch
(3)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Prescription Opioids. IV: Disposition of Hydrocodone in Oral Fluid and Blood Following Single-Dose Administration

Oxycodone/Naloxone: Role in Chronic Pain Management, Opioid-Induced Constipation, and Abuse Deterrence

Prescription Opioids. III. Disposition of Oxycodone in Oral Fluid and Blood Following Controlled Single-Dose Administration

Prevalence of Synthetic Cannabinoids in U.S. Athletes: Initial Findings

Immunoassay in healthcare testing applications

Prescription Opioids. V. Metabolism and Excretion of Oxymorphone in Urine Following Controlled Single Dose Administration

Prescription Opioids. VI. Metabolism and Excretion of Hydromorphone in Urine Following Controlled Single-Dose Administration

Pseudoephedrine and False-Positive Immunoassay Urine Drug Tests for Amphetamine

Uncertainty in Assessing Impact of Drug–Drug Interactions on Oxycodone Metabolite Patterns

Risks and Responsibilities in Prescribing Opioids for Chronic Noncancer Pain, Part 2: Best Practices

Determining Zolpidem Compliance: Urinary Metabolite Detection and Prevalence in Chronic Pain Patients

Prescribing Opioids for Chronic Noncancer Pain in Primary Care: Risk Assessment

Oral Fluid Drug Testing of Chronic Pain Patients. II. Comparison of Paired Oral Fluid and Urine Specimens

Oral Fluid Drug Testing of Chronic Pain Patients. I. Positive Prevalence Rates of Licit and Illicit Drugs

Prevalence of heroin markers in urine for pain management patients

Urine Drug Testing of Chronic Pain Patients. V. Prevalence of Propoxyphene Following its Withdrawal from the United States Market

Urine Drug Testing of Chronic Pain Patients. III. Normetabolites as Biomarkers of Synthetic Opioid Use

Urine Drug Testing of Chronic Pain Patients. IV. Prevalence of Gabapentin and Pregabalin

Drug Testing in Pain Management

Intralesional lymphokine-activated killer cells as adjuvant therapy for primary glioblastoma

Long-term survival for patients with detectable metastatic melanoma at time of treatment with patient-specific tumor stem cell vaccines

Patient-specific immunotherapy utilizing putative tumor stem cells in patients with metastatic melanoma: A pooled analysis comparing tumor cell and dendritic cell vaccines in two phase II trials and a randomized phase II trial

Evidence for a unifocal origin in familial ovarian cancer

Suchergebnisse filtern